Eva Lonn

Eva Lonn

UNVERIFIED PROFILE

Are you Eva Lonn?   Register this Author

Register author
Eva Lonn

Eva Lonn

Publications by authors named "Eva Lonn"

Are you Eva Lonn?   Register this Author

100Publications

3145Reads

15Profile Views

The cost implication of primary prevention in the HOPE 3 trial.

Eur Heart J Qual Care Clin Outcomes 2019 Jul;5(3):266-271

Population Health Research Institute, DBCVSRI, 20 Copeland Avenue, Hamilton, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ehjqcco/qcz001DOI Listing
July 2019

What do physicians need to know in order to 'prescribe' mobile applications to patients with cardiovascular disease?

Per Med 2019 Jul 17;16(4):263-268. Epub 2019 Jul 17.

Department of Medicine, McMaster University, Hamilton, ON, L8S 4L8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pme-2019-0015DOI Listing
July 2019

Impact of blood pressure lowering, cholesterol lowering and their combination in Asians and non-Asians in those without cardiovascular disease: an analysis of the HOPE 3 study.

Eur J Prev Cardiol 2019 May 11;26(7):681-697. Epub 2018 Dec 11.

2 Population Health Research Institute, McMaster University and Hamilton Health Sciences, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2047487318819019DOI Listing
May 2019

Statin Use in Primary Prevention: A Simple Trial-Based Approach Compared With Guideline-Recommended Risk Algorithms for Selection of Eligible Patients.

Can J Cardiol 2019 May 19;35(5):644-652. Epub 2019 Mar 19.

Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada; Department of Medicine and Population Health Research Institute, Hamilton Health Sciences General Site, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cjca.2019.03.002DOI Listing
May 2019

Effects of blood pressure and lipid lowering on cognition: Results from the HOPE-3 study.

Neurology 2019 Mar 27;92(13):e1435-e1446. Epub 2019 Feb 27.

From the Population Health Research Institute (J.B., M. O., B.S., E.M.L., M.S., S.F.L., J.M.P., R.H., S.Y.) and Hamilton Health Sciences (J.B.), School of Rehabilitation Science, McMaster University, Ontario; Institut Universitaire de Cardiologie et Pneumologie de Québec (G.D.), Université Laval, Québec; Li Ka Shing Knowledge Institute (L.A.L.), St. Michael's Hospital, University of Toronto, Ontario, Canada; Research Board Clinical Research Facility (M.O.), Department of Medicine, NUI Galway, Ireland; Instituto Cardiovascular de Rosario (R.D.), Argentina; Diabetes Research Centre (K.K.), University of Leicester; Department of Cardiovascular Sciences and the National Institute for Health Research (W.D.T.), Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, University of Leicester, UK; College of Medicine (A.D.), University of the Philippines, Manila, Philippines; Lady Davis Carmel Medical Center (B.S.L.), Ruth and Bruce Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa; Dante Pazzanese Institute of Cardiology (A.A.), São Paulo, Brazil; Department of Medical Sciences (C.H.), Cardiology, Uppsala Clinical Research Center, Uppsala University, Sweden; Semmelweis University (M.K.), Budapest, Hungary; Monash University (C.R.), Melbourne, Victoria; School of Public Health (C.M.R.), Curtin University, Perth, Australia; and Hatter Institute for Cardiovascular Research in Africa (K.S.), Department of Medicine, University of Cape Town, Soweto Cardiovascular Research Group, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000007174DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453765PMC
March 2019

Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion: The COMPASS-CABG Study.

J Am Coll Cardiol 2019 Jan;73(2):121-130

Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S07351097183906
Publisher Site
http://dx.doi.org/10.1016/j.jacc.2018.10.048DOI Listing
January 2019

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.

N Engl J Med 2017 10 27;377(14):1319-1330. Epub 2017 Aug 27.

From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON (J.W.E., S.J.C., J.B., R.G.H., O.S., E.M.L., S.S.A., D.L., S.Y.), and Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec, QC (G.R.D.) - both in Canada; Estudios Clínicos Latino América and Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Amphia Ziekenhuis and Werkgroep Cardiologische Centra Nederland (WCN), Utrecht, the Netherlands (M.A.); Cardiocenter, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic (P.W.); Osaka International Cancer Institute, Osaka, Japan (M.H.); Instituto Dante Pazzanese de Cardiologia (A.A.), and Hospital do Coração (L.S.P.), São Paulo; University of Washington Medical Center (K.R.H.B.) and University of Washington (J.P.), Seattle; Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston (D.L.B.); FuWai Hospital, Beijing (J.Z., Y.L.); National Association of Hospital Cardiologists Research Center (ANMCO), Florence, Italy (A.P.M.); Research Institute, Fundación Oftalmológica de Santander (FOSCAL)-Bucaramanga, Bucaramanga, Colombia (P.L.-J.); National University of Ireland, Galway (M.O.); Thrombosis Research Institute and University College London, London (A.K.K.), Centre for Cardiovascular Science, University of Edinburgh, Edinburgh (K.A.A.F.), and University of Glasgow, Glasgow (T.J.G.) - all in the United Kingdom; Collegium Medicum Jagiellonian University, Krakow, Poland (T.J.G); Institute of Cardiology, Kiev, Ukraine (A.N.P.); University of Würzburg and University Hospital, Würzburg (G.E., S.S.), and Bayer, Leverkusen (N.C.B., F.M., E.C.) - all in Germany; Semmelweis University, Budapest, Hungary (M.K.); Karolinska Institutet, Stockholm (L.R.); National Research Center for Preventative Medicine, Moscow (N.P.); University of Philippines, Manila (A.L.D.); Universidad de La Frontera, Temuco, Chile (F.L.); University of Cape Town, Cape Town, South Africa (P.J.C.); University of Aalborg, Copenhagen (C.T.-P.); University of Leuven, Leuven, Belgium (P.B.V.); University of Medicine and Pharmacology, Carol Davila University and Emergency Hospital, Bucharest, Romania (D.V.); Catholic University of Korea, Seoul, South Korea (J.-H.K.); Monash University, Melbourne, VIC, Australia (A.M.T.); Lady Davis Carmel Medical Center, Haifa, Israel (B.S.L.); Facultad de Ciencias de la Salud Eugenio Espejo-Universidad Tecnológica Equinoccial, Quito, Ecuador (C.F.); Universiti Teknologi Mara, Selangor, Malaysia (K.Y.); Université Paris Diderot, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Paris (P.G.S.); and Turku University Central Hospital and Turku University, Turku, Finland (K.P.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1709118DOI Listing
October 2017

Association of Apolipoproteins B and A-1 With Markers of Vascular Health or Cardiovascular Events.

Can J Cardiol 2017 10 16;33(10):1305-1311. Epub 2017 Aug 16.

Population Health Research Institute and Department of Medicine, McMaster University Hamilton, Hamilton, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cjca.2017.08.004DOI Listing
October 2017

Primary Prevention With Statin Therapy in the Elderly: New Meta-Analyses From the Contemporary JUPITER and HOPE-3 Randomized Trials.

Circulation 2017 05 6;135(20):1979-1981. Epub 2017 Apr 6.

From Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (P.M.R., N.P.P., R.G.); and the Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada (E.L., S.Y.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.117.028271DOI Listing
May 2017

Diabetes for Cardiologists: Practical Issues in Diagnosis and Management.

Can J Cardiol 2017 03 26;33(3):366-377. Epub 2016 Jul 26.

Division of Endocrinology, McGill University Health Centre, McGill University, Montreal, Québec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cjca.2016.07.512DOI Listing
March 2017

The SPRINT and the HOPE-3 Trial in the Context of Other Blood Pressure-Lowering Trials.

JAMA Cardiol 2016 11;1(8):857-858

Population Health Research Institute, McMaster University, and Hamilton Health Sciences, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamacardio.2016.2169DOI Listing
November 2016

Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mm Hg Target? An Antagonist View From the HOPE-3 Trial (Heart Outcomes Evaluation-3).

Circulation 2016 11 12;134(18):1311-1313. Epub 2016 Sep 12.

From the Department of Medicine and Population Health Research Institute, McMaster University and Hamilton Health Sciences, Ontario, Canada (E.M.L., S.Y.).

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.116.0
Publisher Site
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.023264DOI Listing
November 2016

Blood-Pressure and Cholesterol Lowering in the HOPE-3 Trial.

N Engl J Med 2016 09;375(12):1193-4

McMaster University, Hamilton, ON, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1608916DOI Listing
September 2016

Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.

N Engl J Med 2016 May 2;374(21):2032-43. Epub 2016 Apr 2.

From the Population Health Research Institute, Hamilton Health Sciences (S.Y., E.L., J.B., R.M., J.P., H.J.), Department of Medicine (S.Y., E.L., R.M.), School of Rehabilitation Science (J.B.), Department of Clinical Epidemiology and Biostatistics (J.P.), McMaster University, Hamilton, ON, Li Ka Shing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.), and Institut Universitaire de Cardiologie et Pneumologie de Québec, Université Laval, Quebec, QC (G.D.) - all in Canada; St. John's Research Institute (P.P., D.X.), and St. John's Medical College (D.X.), Bangalore, India; Fundacion Oftalmológica de Santander and Instituto Masira, Medical School, Universidad de Santander, Bucaramanga (P.L.-J.), and Universidad del Norte, Barranquilla (J.L.A.) - both in Colombia; Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (J.Z., L.L.); Dante Pazzanese Institute of Cardiology (A.A.) and HCor-Heart Hospital (L.S.P.), Sao Paulo; Institute of Cardiology, Kiev, Ukraine (A.P.); Hungarian Institute of Cardiology, Semmelweis University, Budapest, Hungary (M.K., K. Keltai); Hatter Institute for Cardiovascular Research in Africa, Department of Medicine, University of Cape Town, Soweto Cardiovascular Research Group, Cape Town, South Africa (K.S.); Institute of Clinical Cardiology in the Russian Cardiology Research Complex, Moscow (I.C.); the Department of Cardiology, Academic Medical Center, Amsterdam (R.J.G.P.); the Department of Medical Sciences, Cardiology, Clinical Research Center, Uppsala University, Uppsala, Sweden (C.H.); Universiti Teknologi Majlis Amansh Rakyat, Selayang, and University College Sedaya International University, Kuala Lumpur (K.Y.) - both in Malaysia; Lady Davis Carmel Medical Center, Ruth and Bruce Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel (B.S.L.); University Hospital Motol, Prague, Czech Repu

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1600177DOI Listing
May 2016

Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

N Engl J Med 2016 May 2;374(21):2021-31. Epub 2016 Apr 2.

From the Population Health Research Institute, Hamilton Health Sciences (S.Y., J.B., R.M., J.P., H.J., P.G., E.L.), Departments of Medicine (S.Y., R.M., E.L.) and Clinical Epidemiology and Biostatistics (J.P.), and School of Rehabilitation Science (J.B.), McMaster University, Hamilton, ON, Institut Universitaire de Cardiologie et Pneumologie de Québec, Université Laval, Quebec, QC (G.D.), and Li Ka Shing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - all in Canada; Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (J.Z., L.L.); St. John's Medical College (D.X.) and St. John's Research Institute (D.X., P.P.), Bangalore, India; Fundacion Oftalmológica de Santander and Instituto Masira, Medical School, Universidad de Santander, Bucaramanga (P.L.-J.), and University of Quindio, Armenia (G.S.-V.) - both in Colombia; College of Medicine, University of the Philippines, Manila (A.D.); Dante Pazzanese Institute of Cardiology (A.A.) and HCor-Heart Hospital (L.S.P.), São Paulo; Institute of Cardiology, Kiev, Ukraine (A.P.); Hungarian Institute of Cardiology, Semmelweis University, Budapest (K. Keltai, M.K.); Hatter Institute for Cardiovascular Research in Africa, Department of Medicine, University of Cape Town, Soweto Cardiovascular Research Group, Cape Town, South Africa (K.S.); Department of Cardiology, Academic Medical Center, Amsterdam (R.J.G.P); Department of Medical Sciences, Cardiology, Clinical Research Center, Uppsala University, Uppsala, Sweden (C.H.); Institute of Clinical Cardiology in the Russian Cardiology Research Complex, Moscow (I.C.); Universiti Teknologi Majlis Amansh Rakyat, Selayang, and University College Sedaya International University, Kuala Lumpur - both in Malaysia (K.Y.); Lady Davis Carmel Medical Center, Ruth and Bruce Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa (B.S.L.); Universi

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1600176DOI Listing
May 2016

Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

N Engl J Med 2016 May 2;374(21):2009-20. Epub 2016 Apr 2.

From the Population Health Research Institute, Hamilton Health Sciences (E.M.L., J.B., R.M., J.P., J.W., H.J., S.Y.), the Department of Medicine (E.M.L., R.M., S.Y.), the School of Rehabilitation Science (J.B.), and the Department of Clinical Epidemiology and Biostatistics (J.P.), McMaster University, Hamilton, ON, Li Ka Shing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.), and Institut Universitaire de Cardiologie et Pneumologie de Québec, Université Laval, Quebec, QC (G.D.) - all in Canada; Fundacion Oftalmológica de Santander and Instituto Masira, Medical School, Universidad de Santander, Bucaramanga (P.L.-J.), and University of Caldas and Institución Prestadora de Salud Internistas de Caldas, Manizales (D.I.M.S.) - both in Colombia; Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (J.Z., L.L.); St. John's Research Institute (P.P., D.X.) and St. John's Medical College (D.X.), Bangalore, India; Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Hatter Institute for Cardiovascular Research in Africa, Department of Medicine, University of Cape Town, Soweto Cardiovascular Research Group, Cape Town, South Africa (K.S.); College of Medicine, University of the Philippines, Manila (A.D.); Dante Pazzanese Institute of Cardiology (A.A.) and HCor-Heart Hospital (L.S.P.) - both in São Paulo; Hungarian Institute of Cardiology, Semmelweis University, Budapest, Hungary (K. Keltai, M.K.); Institute of Clinical Cardiology in the Russian Cardiology Research Complex, Moscow (I.C.); the Department of Cardiology, Academic Medical Center, Amsterdam (R.J.G.P.); the Department of Medical Sciences, Cardiology, Clinical Research Center, Uppsala University, Uppsala, Sweden (C.H.); Universiti Teknologi Majlis Amansh Rakyat, Selayang, and University College Sedaya International University, Kuala Lumpur (K.Y.) - both in Malaysia; Lady Davis Ca

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1600175DOI Listing
May 2016

Association of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) With Cardiovascular Risk in Primary Prevention.

Arterioscler Thromb Vasc Biol 2015 Oct 20;35(10):2254-9. Epub 2015 Aug 20.

From the Libin Cardiovascular Institute of Alberta, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada (Y.M.Z., T.J.A., K.S., M.F.); Department of Laboratory Medicine (M.J.M.), Population Health Research Institute (M.J.M., E.M.L.) and Department of Medicine (E.M.L.), McMaster University Hamilton, Hamilton, Ontario, Canada (E.M.L.); and Department of Surgery, Division of Cardiac Surgery, Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada (S.V.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.115.306172DOI Listing
October 2015

The Relationship Between Trimethylamine-N-Oxide and Prevalent Cardiovascular Disease in a Multiethnic Population Living in Canada.

Can J Cardiol 2015 Sep 25;31(9):1189-94. Epub 2015 Jun 25.

Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cjca.2015.06.016DOI Listing
September 2015

Young Women With Acute Myocardial Infarction and the Posthospital Syndrome.

Circulation 2015 Jul 17;132(3):149-51. Epub 2015 Jun 17.

From Department of Medicine and Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada (I.G., E.L.); and Department of Cardiology, Soroka Medical Center, Ben-Gurion University of the Negev, Be'er-Sheva, Israel (I.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.115.017433DOI Listing
July 2015

The new dyslipidemia guidelines: what is the debate?

Can J Cardiol 2015 May 11;31(5):605-12. Epub 2014 Nov 11.

Robarts Research Institute, Western University, London, Ontario, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0828282X140157
Publisher Site
http://dx.doi.org/10.1016/j.cjca.2014.11.007DOI Listing
May 2015

Common carotid intima-media thickness relates to cardiovascular events in adults aged <45 years.

Hypertension 2015 Apr 26;65(4):707-13. Epub 2015 Jan 26.

From the Department of Radiology (A.L.M.E.), Department of Cardiovascular Epidemiology, Julius Center for Health Sciences and Primary Care (K.A.G., D.E.G., S.A.E.P., M.L.B., H.M.d.R.), and Department of Experimental Cardiology (I.E.H., H.M.d.R.), University Medical Center, Utrecht, Utrecht, The Netherlands; Department of Cardiac Sciences and Libin Cardiovascular Institute of Alberta, University of Calgary, Alberta, Canada (T.J.A.); Department of Epidemiology and Public Health University College London, London, United Kingdom (A.R.B.); Department of Clinical Sciences in Malmö, Lund University, Skåne University Hospital, Malmö, Sweden (G.E., B.H., M.R.); Department of Biostatistical Sciences and Neurology, Wake Forest School of Medicine, Winston-Salem, NC (G.W.E.); Division of Vascular Medicine, Department of General Internal Medicine, Radboud University Medical Centre Nijmegen, Nijmegen, The Netherlands (J.d.G., S.H.); Department of Clinical Epidemiology, University of Malaya Medical Center, Kuala Lumpur, Malaysia (D.E.G.); Osaka Medical Center for Health Science and Promotion, Osaka, Japan (A.I., A.K.); Department of Neurology, Tokyo Women Medical University, Tokyo, Japan (K.K.); Division of Cardiology and Population Health Research Institute, Department of Medicine, McMaster University, Hamilton, Ontario, Canada (E.M.L.); Department of Neurology, University Hospital, Goethe-University, Frankfurt am Main, Germany (M.W.L., M.S.); Brain and Circulation Research Group, Department of Clinical Medicine, University of Tromsø, Tromsø, Norway (E.B.M.); Department of General Practice, EMGO Institute, VU Medical Center, Amsterdam, The Netherlands (G.N., J.M.D.); Stroke Center, Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan (S.O.); Department of Radiology, Tufts Medical Center, Boston, MA (D.H.O'L., J.F.P.); Centre for Population Health Sciences, University of Edinburgh, Edinburgh, United Kingdom (J.F.P., C.R.); Cardiology Division, De

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.114.04658DOI Listing
April 2015

Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular risk.

Hypertension 2015 Mar 12;65(3):651-61. Epub 2015 Jan 12.

From the Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Homburg, Germany (M.B., F.C., U.L.); Boehringer Ingelheim, Pharma GmbH & Co. KG, Ingelheim, Germany (H.S.); Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada (D.L., E.L., K.T., S.Y.); Centro di Fisiologica Clinica e Ipertensione, Universita Milano-Bicocca, Istituto Auxologico, Milan, Italy (G.M.); CARIM-School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands (T.U.); Department of Nephrology and Hypertension, Friedrich-Alexander University, Erlangen, Germany (R.S.); Department of Neurology, University Hospital Essen, Essen, Germany (H.-C.D.); Hatter Institute for Cardiovascular Research in Africa & IIDMM, Faculty of Health Sciences, University of Cape Town, South Africa (K.S.); Hypertension Unit, KU Leuven University, Leuven, Belgium (R.F.); University of Valencia, Spain (J.R.); Department of Cardiovascular Medicine, John Radcliffe Hospital, Oxford, United Kingdom (P.S.); The George Institute for Global Health, University of Sydney and Royal Prince Alfred Hospital, Sydney, NSW, Australia (C.A.); and HRB Clinical Research Facility Galway, National University of Ireland, Galway, Geata an Eolais, University Road, Galway, Ireland (M.O'D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.114.04568DOI Listing
March 2015

Effects of the once-weekly glucagon-like peptide-1 receptor agonist dulaglutide on ambulatory blood pressure and heart rate in patients with type 2 diabetes mellitus.

Hypertension 2014 Oct 30;64(4):731-7. Epub 2014 Jun 30.

From the Tulane University School of Medicine, New Orleans, LA (K.C.F.); Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington (W.B.W.); University of Alabama at Birmingham (D.A.C.); McMaster University, Hamilton, Ontario, Canada (E.M.L.); Sager Consulting, San Francisco, CA (P.T.S.); B2S Consulting, Carmel, IN (R.B.); and Lilly Diabetes, Eli Lilly and Company, Indianapolis, IN (H.H.J., R.J.T., K.E.R., M.J.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.114.03062DOI Listing
October 2014

Gaps in Medical and Device Therapy for Patients with Left Ventricular Systolic Dysfunction: The EchoGap Study.

Open Cardiovasc Med J 2014 30;8:94-101. Epub 2014 Sep 30.

Division of Cardiology, Department of Medicine and the Department of Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1874192401408010094DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4205776PMC
October 2014

Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals.

Am J Clin Nutr 2014 Aug 25;100(2):657-66. Epub 2014 Jun 25.

From the Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, United Kingdom (R Clarke, DB, SP, SL, JA, JH, and R Collins); the Department of Human Nutrition, University of Otago, Dunedin, New Zealand (MS); the Section for Pharmacology and Department of Public Health and Primary Care, University of Bergen, Bergen, Norway (SJPME); the Department of Epidemiology, School for Public Health and Primary Care, CAPHRI, Maastricht University Medical Centre, Maastricht, Netherlands (SJPME); the Section of Hematology and Coagulation, Department of Internal Medicine, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden (CL); the Division of Cardiovascular and Medical Science, University of Glasgow, Glasgow, United Kingdom (DJS); the School of Medicine and Pharmacology, The University of Western Australia, Perth, Australia (GJH); the Population Health Research Institute and Department of Medicine, McMaster University, Hamilton, Canada (EL); the Department of Neurology, Western University, London, Canada (JDS); Unité de Recherche en Epidémiologie Nutritonnelle (UREN), Sorbonne-Paris-Cité, UMR Inserm U557, France (PG); Inra U1125, Paris, France (PG); Cnam, Paris, France (PG); Université Paris 13, CRNH IdF, Bobigny, France (PG); the Division of Human Nutrition and Epidemiology, Wageningen University, Wageningen, Netherlands (LCdG); the Department of Nutrition and Public Health Intervention Research, London School of Hygiene and Tropical Medicine, London, United Kingdom (ADD); and the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA (FG).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3945/ajcn.113.076349DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095663PMC
August 2014

The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.

Eur J Prev Cardiol 2014 Mar 4;21(3):299-309. Epub 2013 Nov 4.

Department of Clinical Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2047487313510678DOI Listing
March 2014

Identification and management of patients at elevated cardiometabolic risk in canadian primary care: how well are we doing?

Can J Cardiol 2013 Aug 7;29(8):960-8. Epub 2013 Mar 7.

Division of Endocrinology and Metabolism, Keenan Research Centre in the Li Ka Shing Knowledge Institute of St Michael's Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cjca.2012.12.001DOI Listing
August 2013

Measures of cardiovascular risk and subclinical atherosclerosis in a cohort of women with a remote history of preeclampsia.

Atherosclerosis 2013 Jul 25;229(1):234-9. Epub 2013 Apr 25.

Departments of Obstetrics and Gynecology (Division of Maternal-Fetal Medicine) and Radiology, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2013.04.020DOI Listing
July 2013

Pneumococcal endocarditis causing valve destruction in the absence of vegetations on transesophageal echocardiography: a series of 3 consecutive cases.

Can J Cardiol 2013 Apr 24;29(4):519.e7-9. Epub 2012 Aug 24.

Division of Cardiology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cjca.2012.06.022DOI Listing
April 2013

The relationship between anthropometric indexes of adiposity and vascular function in the FATE cohort.

Obesity (Silver Spring) 2013 Feb;21(2):266-73

Department of Cardiac Sciences and Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/oby.20266DOI Listing
February 2013

Alcohol consumption and the risk of incident atrial fibrillation among people with cardiovascular disease.

CMAJ 2012 Nov 1;184(16):E857-66. Epub 2012 Oct 1.

Hamilton Health Sciences,McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1503/cmaj.120412DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494322PMC
November 2012

Multivitamins in prevention of cardiovascular disease.

Authors:
Eva M Lonn

JAMA 2012 Nov;308(17):1802-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2012.28259DOI Listing
November 2012

Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?

Eur Heart J 2012 May 15;33(9):1049-57. Epub 2012 Mar 15.

INSERM, Centre d'Investigation Clinique 9501 and Unité 961, Centre Hospitalier Universitaire, and the Department of Cardiology, Nancy University, Hôpital Jeanne d' Arc, 54200 Toul, Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehr437DOI Listing
May 2012

Cardiovascular risk factors and subclinical atherosclerosis among Nunavik Inuit.

Atherosclerosis 2012 Apr 12;221(2):558-64. Epub 2012 Jan 12.

Unité de Recherche en Santé Publique, Université Laval, 2875 Boulevard Laurier, Édifice Delta 2, Bureau 600, Québec, Québec G1V 2M2, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2012.01.012DOI Listing
April 2012

Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) study.

Eur Heart J 2011 Sep 17;32(17):2135-42. Epub 2011 Mar 17.

Division of Cardiac Surgery, Keenan Research Centre in the Li Ka Shing Knowledge Institute of St Michael's, University of Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehr066DOI Listing
September 2011

Microvascular function predicts cardiovascular events in primary prevention: long-term results from the Firefighters and Their Endothelium (FATE) study.

Circulation 2011 Jan 3;123(2):163-9. Epub 2011 Jan 3.

Department of Cardiac Sciences and Libin Cardiovascular Institute of Alberta, University of Calgary, 1403-29th St. NW, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.110.953653DOI Listing
January 2011

Relation between obesity and the attainment of optimal blood pressure and lipid targets in high vascular risk outpatients.

Am J Cardiol 2010 Nov;106(9):1270-6

Terrence Donnelly Heart Centre, St. Michael's Hospital, University of Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2010.06.055DOI Listing
November 2010

The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions.

Circulation 2010 Nov;122(20):2078-88

Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.109.873232DOI Listing
November 2010

Lipoprotein-associated phospholipase A2: a new therapeutic target.

Authors:
Eva Lonn

Can J Cardiol 2010 Mar;26 Suppl A:27A-31A

Hamilton Health Sciences and Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0828-282x(10)71058-8DOI Listing
March 2010

Polypill: the evidence and the promise.

Curr Opin Lipidol 2009 Dec;20(6):453-9

Population Health Research Institute and Department of Medicine, Division of Cardiology, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOL.0b013e32833305a3DOI Listing
December 2009

The differential association between various anthropometric indices of obesity and subclinical atherosclerosis.

Atherosclerosis 2009 Nov 16;207(1):232-8. Epub 2009 Apr 16.

Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2009.03.053DOI Listing
November 2009

The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial.

J Cardiovasc Electrophysiol 2009 Jul 27;20(7):781-7. Epub 2009 Feb 27.

Department of Medicine, Division of Cardiology, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1540-8167.2009.01440.x
Publisher Site
http://dx.doi.org/10.1111/j.1540-8167.2009.01440.xDOI Listing
July 2009

5 flourouracil-induced apical ballooning syndrome: a case report.

Blood Coagul Fibrinolysis 2009 Jun;20(4):306-8

Department of Clinical Medicine, University of Insubria, Varese, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MBC.0b013e328329e431DOI Listing
June 2009

Comparison of new measures of vascular function to flow mediated dilatation as a measure of cardiovascular risk factors.

Am J Cardiol 2009 Jun 8;103(11):1610-5. Epub 2009 Apr 8.

Libin Cardiovascular Institute, Department of Cardiac Sciences, University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2009.01.376DOI Listing
June 2009

Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial.

Stroke 2009 Apr 19;40(4):1365-72. Epub 2009 Feb 19.

Department of Medicine, Division of Neurology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/STROKEAHA.108.529503DOI Listing
April 2009

Brain natriuretic peptide as a preclinical marker of chronic pulmonary hypertension in patients with pulmonary embolism.

Intern Emerg Med 2009 Apr 27;4(2):123-8. Epub 2009 Feb 27.

Department of Clinical Medicine, University of Insubria, Varese, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11739-009-0231-xDOI Listing
April 2009

Lipid lowering for primary prevention.

Lancet 2009 Apr;373(9670):1152-5

Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(09)60357-3DOI Listing
April 2009

Hemodynamic performance of stentless versus stented valves: a systematic review and meta-analysis.

J Card Surg 2008 Sep-Oct;23(5):556-64

London Health Sciences Centre, University of Western Ontario, London, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1540-8191.2008.00705.xDOI Listing
March 2009

BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction.

Eur J Heart Fail 2008 Mar;10(3):252-9

Population Health Research Institute and McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1016/j.ejheart.2008.01.017
Publisher Site
http://dx.doi.org/10.1016/j.ejheart.2008.01.017DOI Listing
March 2008